Bionomics to Participate in Upcoming September Investor Conferences
August 31, 2022 06:00 ET
|
Bionomics Ltd
ADELAIDE, Australia, Aug. 31, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (ASX:BNO Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biopharmaceutical company developing novel, allosteric ion...
Bionomics reports Full Year Financial Results
August 25, 2022 06:00 ET
|
Bionomics Ltd
ADELAIDE, Australia, Aug. 25, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (ASX:BNO, Nasdaq:BNOX), today announced its financial results for the 12 months ended 30 June 2022. Bionomics is a clinical...
Qualis Innovations Inc. enters into an Agreement with CIM Securities to raise up to $4,000,000 in Funding
August 24, 2022 09:00 ET
|
Qualis Innovations, Inc.
Chadds Ford, Pennsylvania, Aug. 24, 2022 (GLOBE NEWSWIRE) -- Qualis Innovations Inc. currently trades under the symbol “QLIS” entered into an agreement with CIM Securities to raise up to $4,000,000...
Vyant Bio Reports Second Quarter and First Half 2022 Results and Provides Strategic and Business Highlights
August 22, 2022 16:10 ET
|
Vyant Bio, Inc.
Conference Call and Webcast Today at 4:30 pm ET Scientific and Business Highlights Based on preclinical efficacy data in our human Rett cortical organoid model, we are advancing VYNT0126 into...
Qualis Innovations Inc. will Present at the 16th PAINWEEK Conference September 6-9 at The Cosmopolitan Of Las Vegas
August 22, 2022 09:53 ET
|
Qualis Innovations, Inc.
Chadds Ford, Pennsylvania, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Qualis Innovations Inc. currently trades under symbol “QLIS”, will be presenting at PAINWEEK 2022. The conference will be held from...
Vyant Bio Announces Rescheduled Investor Conference Call and Webcast for the Second Quarter and First Half of 2022
August 19, 2022 09:29 ET
|
Vyant Bio, Inc.
CHERRY HILL, N.J., Aug. 19, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT) is an innovative biotechnology company reinventing drug discovery for complex...
Vyant Bio Postpones Second Quarter Investor Conference Call and Webcast
August 15, 2022 08:05 ET
|
Vyant Bio, Inc.
CHERRY HILL, N.J., Aug. 15, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT) is an innovative biotechnology company reinventing drug discovery for complex...
Axsome Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
August 09, 2022 07:00 ET
|
Axsome Therapeutics, Inc.
Company to host conference call today at 8:00 AM Eastern NEW YORK, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and...
Bionomics Receives R&D Tax Incentive Refund for FY2021 of A$2.1M
August 08, 2022 06:00 ET
|
Bionomics Ltd
ADELAIDE, Australia, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (ASX: BNO, NASDAQ:BNOX), a clinical stage biopharmaceutical company, is pleased to announce that the Company has received...
Praxis Precision Medicines to Present at 2022 Wedbush PacGrow Healthcare Conference
August 03, 2022 09:00 ET
|
Praxis Precision Medicines, Inc.
BOSTON, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies...